Hepatitis C virus p7-a viroporin crucial for virus assembly and an emerging target for antiviral therapy.
about
Entry inhibitors: New advances in HCV treatmentRelevance of Viroporin Ion Channel Activity on Viral Replication and PathogenesisHepatitis C virus molecular evolution: transmission, disease progression and antiviral therapyThe p7 protein of hepatitis C virus forms structurally plastic, minimalist ion channelsA combined proteomics/genomics approach links hepatitis C virus infection with nonsense-mediated mRNA decayTopology and biological function of enterovirus non-structural protein 2B as a member of the viroporin familyTransverse relaxation dispersion of the p7 membrane channel from hepatitis C virus reveals conformational breathingDetergent-resistant membrane association of NS2 and E2 during hepatitis C virus replicationRelating structure and function of viral membrane-spanning miniproteinsA p7 Ion Channel-derived Peptide Inhibits Hepatitis C Virus Infection in VitroThe ns12.9 Accessory Protein of Human Coronavirus OC43 Is a Viroporin Involved in Virion Morphogenesis and Pathogenesis.Subcellular localization and function of an epitope-tagged p7 viroporin in hepatitis C virus-producing cellsIon Channel Function and Cross-Species Determinants in Viral Assembly of Nonprimate Hepacivirus p7Efficiency of E2-p7 processing modulates production of infectious hepatitis C virusThe molecular and structural basis of advanced antiviral therapy for hepatitis C virus infection.Viroporins, Examples of the Two-Stage Membrane Protein Folding Model.The amino-terminus of the hepatitis C virus (HCV) p7 viroporin and its cleavage from glycoprotein E2-p7 precursor determine specific infectivity and secretion levels of HCV particle types.
P2860
Q26770817-DB5BE0AE-0528-494D-A9ED-AA9B043CC6C7Q26823195-93027D39-69D2-425F-A5D5-5B2C60668CA7Q26853500-068F880C-39BC-4685-93C3-0F4486567A6AQ27329756-DC725D3B-7DB8-4939-ADE1-C5E153F4AECCQ28115899-DE786F31-A853-45E1-9684-34ED7FCCF1F8Q34136039-ADC7824A-FD80-48C6-89A8-2C14C481032FQ35434489-365A0E71-7DAB-4F67-BCE6-B8C1CE3D65B2Q35641053-51A429B8-43A7-4893-AA45-7BEF2A4E095CQ35767097-6F7819C4-AD07-416E-8F91-F159A5ED1DF6Q36281607-941908C6-1B26-4BA2-93A2-61E9B57B3C8AQ36281808-01A98B65-AA7D-44D5-9598-6127B58BA4A0Q36559831-EB3644E9-3C2F-4275-A37E-E480E7E40FCBQ36878871-F040003C-695D-411A-BC2C-8842C9B545A0Q37252600-8273D871-CF02-4DE7-8842-53A948F5F19BQ38113079-7A8FC0B3-56E2-4A5E-BE08-61452AAD513EQ38541409-ACEBDCBF-33E7-4EAE-A9E8-18B298D2463FQ47280477-F26DCF97-81B0-460A-B0C8-0C06282663D7
P2860
Hepatitis C virus p7-a viroporin crucial for virus assembly and an emerging target for antiviral therapy.
description
2010 nî lūn-bûn
@nan
2010年の論文
@ja
2010年学术文章
@wuu
2010年学术文章
@zh-cn
2010年学术文章
@zh-hans
2010年学术文章
@zh-my
2010年学术文章
@zh-sg
2010年學術文章
@yue
2010年學術文章
@zh
2010年學術文章
@zh-hant
name
Hepatitis C virus p7-a viropor ...... target for antiviral therapy.
@en
type
label
Hepatitis C virus p7-a viropor ...... target for antiviral therapy.
@en
prefLabel
Hepatitis C virus p7-a viropor ...... target for antiviral therapy.
@en
P2860
P356
P1433
P1476
Hepatitis C virus p7-a viropor ...... target for antiviral therapy.
@en
P2093
Thomas Pietschmann
P2860
P304
P356
10.3390/V2092078
P577
2010-09-27T00:00:00Z